Below you can find all available PDX models from different research groups sorted by the WHO classification (5th edition). More information about the models can be found in the
datasheets.
If you are interested in a model, please contact the corresponding researcher directly (contact information can be found in the datasheets).
JOIN THE HUSARC INITIATIVE: If you would like to participate in the HUSARC project by making your sarcoma models available to other researchers, please contact us (contact@husarc.org).
Fibroblastic and myofibroblastic tumours
- Abdominal fibromatosis 8822/1
- Dermatofibrosarcoma protuberans NOS DFSP 8832/1
- Dermatofibrosarcoma protuberans with myoid differentiation 8832/3
- Dermatofibrosarcoma protuberans, fibrosarcomatous 8832/3
- Desmoid-type fibromatosis 8821/1
- Epithelioid inflammatory myofibroblastic sarcoma 8825/1
- Epithelioid myxofibrosarcoma 8811/3
- Extra-abdominal desmoid 8821/1
- Fat-forming (lipomatous) solitary fibrous tumour 8815/1
- Fibrosarcoma NOS 8810/3
- Giant cell fibroblastoma 8834/1
- Giant cell-rich solitary fibrous tumour 8815/1
- Infantile fibrosarcoma 8814/3
- Inflammatory myofibroblastic tumour 8825/1
- Lipofibromatosis 8851/1
- Low-grade fibromyxoid sarcoma 8840/3
- Myofibroblastic sarcoma 8825/3
-
Myxofibrosarcoma MFS 8811/3
- Myxoid dermatofibrosarcoma protuberans 8832/3
- Myxoinflammatory fibroblastic sarcoma 8811/1
- Palmar/plantar-type fibromatosis 8813/1
- Pigmented dermatofibrosarcoma protuberans 8833/1
- Plaque-like dermatofibrosarcoma protuberans 8832/3
- Sclerosing epithelioid fibrosarcoma 8840/3
- Solitary fibrous tumour NOS SFT 8815/1
- Solitary fibrous tumour, benign 8815/0
- Solitary fibrous tumour, malignant 8815/3
- Superficial CD34-positive fibroblastic tumour 8810/1
So-called fibrohistiocytic tumours
-
Giant cell tumour of soft parts NOS 9251/1
-
Malignant tenosynovial giant cell tumour 9252/3
-
Plexiform fibrohistiocytic tumour 8835/1
Gastrointestinal stromal tumours
Peripheral nerve sheath tumours
Tumours of uncertain differentiation
-
Angiomyolipoma, epithelioid 8860/1
-
Atypical fibroxanthoma 8830/1
-
Classic epithelioid sarcoma 8804/3
-
Clear cell sarcoma NOS CSS 9044/3
-
Desmoplastic small round cell tumour 8806/3
-
Epithelioid sarcoma 8804/3
-
Extraskeletal myxoid chondrosarcoma 9231/3
-
Haemosiderotic fibrolipomatous tumour 8811/1
-
Intimal sarcoma 9137/3
-
Mixed tumour NOS 8940/0
-
Mixed tumour, malignant, NOS 8940/3
-
Myoepithelial carcinoma 8982/3
-
Myoepithelioma NOS 8982/0
-
Ossifying fibromyxoid tumour NOS 8842/0
-
Ossifying fibromyxoid tumour, malignant 8842/3
-
Perivascular epithelioid tumour, malignant 8714/3
-
Phosphaturic mesenchymal tumour, malignant NTRK-rearranged spindle cell neoplasm (emerging) 8990/3
-
Pleomorphic sarcoma, undifferentiated UPS 8802/3
-
Proximal or large cell epithelioid sarcoma 8804/3
-
Rhabdoid tumour NOS 8963/3
-
Round cell sarcoma, undifferentiated 8803/3
-
Spindle cell sarcoma, undifferentiated 8801/3
-
Synovial sarcoma NOS 9040/3
-
Synovial sarcoma, biphasic 9043/3
-
Synovial sarcoma, poorly differentiated 9043/3
-
Synovial sarcoma, spindle cell 9041/3
-
Undifferentiated sarcoma 8805/3
Undifferentiated small round cell sarcomas of bone and soft tissue
- CIC-rearranged sarcomas 9367/3
- Ewing sarcoma 9364/3
- Round cell sarcoma with EWSR1-non-ETS fusions 9366/3
- Sarcoma with BCOR genetic alterations 9368/3
Osteoclastic giant cell-rich tumours
- Giant cell tumour of bone NOS 9250/1
- Giant cell tumour of bone, malignant 9250/3
Other mesenchymal tumours of bone
- Adamantinoma of long bones (Dedifferentiated adamantinoma) 9261/3
- Leiomyosarcoma NOS 8890/3
- Mesenchymoma NOS 8990/1
- Osteofibrous dysplasia-like adamantinoma 9261/1
- Pleomorphic sarcoma, undifferentiated (Bone metastases) 8802/3